The reliability of point-of-care (POC) prothrombin time testing -: A comparison of CoaguChek XS® INR measurements with hospital laboratory monitoring

被引：1
|
作者：
Ryan, Fiona [1 ]
O'Shea, Susan [2 ]
Ortel, Thomas L. [3 ]
Byrne, Stephen [1 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Pharmaceut Care Res Grp, Cork, Ireland
[2] Cork Univ Hosp, Dept Haematol, Cork, Ireland
[3] Duke Univ, Dept Med, Durham, NC 27706 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.973.973
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
973
引用
收藏
页码：296A / 296A
页数：1
相关论文
共 50 条
  • [41] Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek™ S point-of-care monitor and a robust education program
    Newall, Fiona
    Monagle, Paul
    Johnston, Linda
    THROMBOSIS RESEARCH, 2006, 118 (05) : 587 - 593
  • [42] Quality assessment of CoaguChek point-of-care prothrombin time monitors: Comparison of the European Community-approved procedure and conventional external quality assessment
    Poller, Leon
    Keown, Michelle
    Ibrahim, Saied A.
    van der Meer, Felix J. M.
    van den Besselaar, Anton M. H. P.
    Tripodi, Armando
    Jespersen, Jorgen
    Meijer, Pieter
    Kluft, Cornelis
    CLINICAL CHEMISTRY, 2006, 52 (10) : 1843 - 1847
  • [43] Efficacy of a Point-of-Care INR Device Compared to Laboratory Testing In Patients Starting on a Warfarin Nomogram
    Lewis, Geoffrey M.
    Evans, Mark
    Hutton, Brian
    Rodger, Marc
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 : 65 - 65
  • [44] European Concerted Action on Anticoagulation (ECAA): International normalized ratio variability of CoaguChek and TAS point-of-care testing whole blood prothrombin time monitors
    Poller, L
    Keown, M
    Chauhan, N
    Shiach, C
    van den Besselaar, AMHP
    Tripodi, A
    Jespersen, J
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (06) : 992 - 995
  • [45] CoaguChek (R) XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome (vol 31, pg 1, 2022)
    Fonseca, M. E. S.
    Balbi, G. G. M.
    Signorelli, F.
    Gouvea, C. P.
    de Andrade, D. C. O.
    LUPUS, 2022, 31 (05) : 646 - 646
  • [46] GLUCOSE LEVELS IN CRITICALLY ILL PATIENTS: POINT-OF-CARE (POC) TESTING VERSUS CENTRAL LABORATORY VALUES
    Arce-Delgado, S.
    Bernat-Adell, A.
    Blanch-Eixarch, F.
    Ferrandiz-Selles, A.
    Guillamon-Navarro, S.
    Mateu-Campos, L.
    DeLeon-Belmar, J.
    INTENSIVE CARE MEDICINE, 2010, 36 : S219 - S219
  • [47] Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory
    Yang, W.
    Hosgood, G.
    Luobikis, K.
    Paul, A.
    AUSTRALIAN VETERINARY JOURNAL, 2018, 96 (10) : 379 - 384
  • [48] Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years' experience
    Kitchen, Dianne Patricia
    Kitchen, Steven
    Jennings, Ian
    Al Woods, Timothy
    Fitzmaurice, David A.
    Murray, Ellen T.
    Walker, Isobel D.
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (12) : 1119 - 1123
  • [49] Comparison of international normalized ratio (INR) from a standard lab test and two point-of-care devices, Protime® (PRT) and Coaguchek® (CC).
    Hei, DL
    Taylor, JR
    Kilroy, RA
    Lopez, LM
    BLOOD, 2000, 96 (11) : 652A - 652A
  • [50] COST-ANALYSIS OF POINT-OF-CARE LABORATORY TESTING IN A COMMUNITY-HOSPITAL
    NOSANCHUK, JS
    KEEFNER, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1995, 103 (02) : 240 - 243
12345